Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis

FASEB Journal

Volumn 18, Issue 11, 2004, Pages 1185-1191

  Weaver, Joel G R ^a,b   Rouse, Mark S ^b   Steckelberg, James M ^b   Badley, Andrew D ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

CLP; Cytokine; Lymphocyte; Protease inhibitor; SIRS

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT; APOPTOSIS INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6; NELFINAVIR; PROTEINASE INHIBITOR; RAG1 PROTEIN; RITONAVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL GROWTH; BLOOD CULTURE; CECUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; STREPTOCOCCUS BOVIS; SURVIVAL RATE; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; CECUM; CYTOKINES; DRUG EVALUATION, PRECLINICAL; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GENES, RAG-1; GERM-FREE LIFE; INTESTINAL PERFORATION; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROBIAL SENSITIVITY TESTS; NELFINAVIR; PROTEASE INHIBITORS; PSEUDOMONAS AERUGINOSA; RITONAVIR; SEPSIS; SPLEEN; STREPTOCOCCUS BOVIS; THYMUS GLAND;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ESCHERICHIA COLI; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS; STREPTOCOCCUS BOVIS;

EID: 3442885900     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.03-1230com     Document Type: Article

References (74)

1. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M. R. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310
2. Martin, G. S., Mannino, D. M., Eaton, S., and Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554
3. Debets, J. M., Kampmeijer, R., van der Linden, M. P., Buurman, W. A., and van der Linden, C. J. (1989) Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit. Care Med. 17, 489-494
4. Oberholzer, A., Oberholzer, C., and Moldawer, L. L. (2000) Cytokine signaling-regulation of the immune response in normal and critically ill states. Crit. Care Med. 28, N3-12
5. Pruitt, J. H., Welborn, M. B., Edwards, P. D., Harward, T. R., Seeger, J. W., Martin, T. D., Smith, C., Kenney, J. A., Wesdorp, R. I., Meijer, S., et al. (1996) Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87, 3282-3288
6. Rogy, M. A., Coyle, S. M., Oldenburg, H. S., Rock, C. S., Barie, P. S., Van Zee, K. J., Smith, C. G., Moldawer, L. L., and Lowry, S. F. (1994) Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J. Am. Coll. Surg. 178, 132-138
7. Meakins, J. L., Pietsch, J. B., Bubenick, O., Kelly, R., Rode, H., Gordon, J., and MacLean, L. D. (1977) Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann. Surg. 186, 241-250
8. Lederer, J. A., Rodrick, M. L., and Mannick, J. A. (1999) The effects of injury on the adaptive immune response. Shock 11, 153-159
9. Oberholzer, A., Oberholzer, C., and Moldawer, L. L. (2001) Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16, 83-96
10. Wang, S. D., Huang, K. J., Lin, Y. S., and Lei, H. Y. (1994) Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152, 5014-5021
11. Ayala, A., Herdon, C. D., Lehman, D. L., Ayala, C. A., and Chaudry, I. H. (1996) Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87, 4261-4275
12. Hotchkiss, R. S., Swanson, P. E., Cobb, J. P., Jacobson, A., Buchman, T. G., and Karl, I. E. (1997) Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit. Care Med. 25, 1298-1307
13. Hotchkiss, R. S., Dunne, W. M., Swanson, P. E., Davis, C. G., Tinsley, K W., Chang, K. C., Buchman, T. G., and Karl, I. E. (2001) Role of apoptosis in Pseudomonas aeruginosa pneumonia. Science 294, 1783
14. Chung, C. S., Wang, W., Chaudry, I. H., and Ayala, A. (2001) Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated. Am. J. Physiol. 280, G812-G818
15. Freeman, B. D., Reaume, A. G., Swanson, P. E., Epstein, C. J., Carlson, E. J., Buchman, T. G., Karl, I. E., and Hotchkiss, R. S. (2000) Role of CuZn superoxide dismutase in regulating lymphocyte apoptosis during sepsis. Crit. Care Med. 28, 1701-1708
16. Hotchkiss, R. S., Tinsley, K. W., Hui, J. J., Chang, K. C., Swanson, P. E., Drewry, A. M., Buchman, T. G., and Karl, I. E. (2000) p53-dependent and -independent pathways of apoptotic cell death in sepsis. J. Immunol. 164, 3675-3680
17. Tinsley, K. W., Cheng, S. L., Buchman, T. G., Chang, K. C., Hui, J. J., Swanson, P. E., Karl, I. E., and Hotchkiss, R. S. (2000) Caspases -2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis. Shock 13, 1-7
18. Ayala, A., Xin Xu, Y., Ayala, C. A., Sonefeld, D. E., Karr, S. M., Evans, T. A., and Chaudry, I. H. (1998) Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood 91, 1362-1372
19. Husain, K. D., and Coopersmith, C. M. (2003) Role of intestinal epithelial apoptosis in survival. Curr. Opin. Crit. Care 9, 159-163
20. Coopersmith, C. M., Stromberg, P. E., Dunne, W. M., Davis, C. G., Amiot, D. M., II, Buchman, T. G., Karl, I. E., and Hotchkiss, R. S. (2002) Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. J. Am. Med. Assoc. 287, 1716-1721
21. Coopersmith, C. M., Stromberg, P. E., Davis, C. G., Dunne, W. M., Amiot, D. M., II, Karl, I. E., Hotchkiss, R. S., and Buchman, T. G. (2003) Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit. Care Med. 31, 1630-1637
22. Coopersmith, C. M., Chang, K. C., Swanson, P. E., Tinsley, K. W., Stromberg, P. E., Buchman, T. G., Karl, I. F., and Hotchkiss, R. S. (2002) Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit. Care Med. 30, 195-201
23. Hotchkiss, R. S., Swanson, P. E., Freeman, B. D., Tinsley, K. W., Cobb, J. P., Matuschak, G. M., Buchman, T. G., and Karl, I. E. (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27, 1230-1251
24. Coutinho, H. B., Robalinho, T. I., Coutinho, V. B., Amorim, A. M., Furtado, A. F., Ferraz, A., Ferraz, E., Walker, F., King, G., Sewell, H. F., et al. (1997) Intra-abdominal sepsis: an immunocytochemical study of the small intestine mucosa. J. Clin. Pathol. 50, 294-298
25. Zeerleder, S., Zwart, B., Wuillemin, W. A., Aarden, L. A., Groeneveld, A. B., Caliezi, C., van Nieuwenhuijze, A. E., van Mierlo, G. J., Eerenberg, A. J., Lammle, B., et al. (2003) Elevated nucleosome levels in systemic inflammation and sepsis. Crit. Care Med. 31, 1947-1951
26. Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Chang, K. C., Cobb, J. P., Buchman, T. G., Korsmeyer, S. J., and Karl, I. E. (1999) Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96, 14541-14546
27. Hotchkiss, R. S., Chang, K. C., Swanson, P. E., Tinsley, K. W., Hui, J. J., Klender, P., Xanthoudakis, S., Roy, S., Black, C., Grimm, E., et al. (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1, 496-501
28. Riedemann, N. C., Guo, R. F., and Ward, P. A. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524
29. Hotchkiss, R. S., Swanson, P. E., Knudson, C. M., Chang, K. C., Cobb, J. P., Osborne, D. F., Zollner, K. M., Buchman, T. G., Korsmeyer, S. J., and Karl, I. E. (1999) Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol. 162, 4148-4156
30. Chung, C. S., Song, G. Y., Lomas, J., Simms, H. H., Chaudry, I. H., and Ayala, A. (2003) Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J. Leukoc. Biol. 74, 344-351
31. Hotchkiss, R. S., and Karl, I. E. (2003) The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138-150
32. Oberholzer, C., Oberholzer, A., Clare-Salzler, M., and Moldawer, L. L. (2001) Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J. 15, 879-892
33. Badley, A. D., Dockrell, D. H., Algeciras, A., Ziesmer, S., Landay, A., Lederman, M. M., Connick, E., Kessler, H., Kuritzkes, D., Lynch, D. H., et al. (1998) In vivo analysis of Fas/FasL interactions in HIV-infected patients. J. Clin. Invest. 102, 79-87
34. Phenix, B. N., Angel, J. B., Mandy, F., Kravcik, S., Parato, K., Chambers, K. A., Gallicano, K., Hawley-Foss, N., Cassol, S., Cameron, D. W., et al. (2000) Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. AIDS Res. Hum. Retroviruses 16, 559-567
35. Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debre, P., and Leibowitch, J. (1997) Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277, 112-116
36. Phenix, B. N., Lum, J. J., Nie, Z., Sanchez-Dardon, J., and Badley, A. D. (2001) Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss. Blood 98, 1078-1085
37. Chaudry, I. H., Wichterman, K. A., and Baue, A. E. (1979) Effect of sepsis on tissue adenine nucleotide levels. Surgery 85, 205-211
38. Remick, D. G., Newcomb, D. E., Bolgos, G. L., and Call, D. R. (2000) Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13, 110-116
39. Baker, C. C., Chaudry, I. H., Gaines, H. O., and Baue, A. E. (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94, 331-335
40. National and Standards, C. L. (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-sixth edition. In Approved Standards, 6th edition (M7-A6, N. d., ed) Wayne, Pennsylvania
41. Pellegrin, I., Breilh, D., Montestruc, F., Caumont, A., Garrigue, I., Morlat, P., Le Camus, C., Saux, M. C., Fleury, H. J., and Pellegrin, J. L. (2002) Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VI-RAPHAR study). AIDS 16, 1331-1340
42. O'Reilly, M., Newcomb, D. E., and Remick, D. (1999) Endotoxin, sepsis, and the primrose path. Shock 12, 411-420
43. Fink, M. P., and Heard, S. O. (1990) Laboratory models of sepsis and septic shock. J. Surg. Res. 49, 186-196
44. Deitch, E. A. (1998) Animal models of sepsis and shock: a review and lessons learned. Shock 9, 1-11
45. Echtenacher, B., Weigl, K., Lehn, N., and Mannel, D. N. (2001) Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infect. Immun. 69, 3550-3555
46. Eskandari, M. K., Bolgos, G., Miller, C., Nguyen, D. T., DeForge, L. E., and Remick, D. G. (1992) Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148, 2724-2730
47. Fisher, C. J., Jr., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M., and Benjamin, E. (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N. Engl. J. Med. 334, 1697-1702
48. Gogos, C. A., Drosou, E., Bassaris, H. P., and Skoutelis, A. (2000) Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J. Infect. Dis. 181, 176-180
49. Heidecke, C. D., Hensler, T., Weighardt, H., Zantl, N., Wagner, H., Siewert, J. R., and Holzmann, B. (1999) Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am. J. Surg. 178, 288-292
50. Pellegrini, J. D., De, A. K., Kodys, K., Puyana, J. C., Furse, R. K., and Miller-Graziano, C. (2000) Relationships between T lymphocyte apoptosis and anergy following trauma. J. Surg. Res. 88, 200-206
51. Ayala, A., Ertel, W., and Chaudry, I. H. (1996) Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 5, 79-90
52. Green, D. R., and Beere, H. M. (2000) Apoptosis. Gone but not forgotten. Nature (London) 405, 28-29
53. Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., and Girkontaite, I. (1997) Immunosuppressive effects of apoptotic cells. Nature (London) 390, 350-351
54. Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A., and Henson, P. M. (2000) A receptor for phosphatidyl-serine-specific clearance of apoptotic cells. Nature (London) 405, 85-90
55. Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Jr., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G., et al. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166, 6952-6963
56. Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Grayson, M. H., Osborne, D. F., Wagner, T. H., Cobb, J. P., Coopersmith, C., and Karl, I. E. (2002) Depletion of dendritic cells, but not macrophages, in patients with sepsis. J. Immunol. 168, 2493-2500
57. Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., and Henson, P. M. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101, 890-898
58. McDonald, P. P., Fadok, V. A., Bratton, D., and Henson, P. M. (1999) Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells. J. Immunol. 163, 6164-6172
59. Chen, W., Frank, M. E., Jin, W., and Wahl, S. M. (2001) TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14, 715-725
60. Barker, R. N., Erwig, L., Pearce, W. P., Devine, A., and Rees, A. J. (1999) Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology 67, 302-305
61. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. (2000) Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423-434
62. Hotchkiss, R. S., Chang, K. C., Grayson, M. H., Tinsley, K. W., Dunne, B. S., Davis, C. G., Osborne, D. F., and Karl, I. E. (2003) Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl. Acad. Sci. USA 100, 6724-6729
63. Hiramatsu, M., Hotchkiss, R. S., Karl, I. E., and Buchman, T. G. (1997) Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock 7, 247-253
64. Sileri, P., Morini, S., Sica, G. S., Schena, S., Rastellini, C., Gaspari, A. L., Benedetti, E., and Cicalese, L. (2002) Bacterial translocation and intestinal morphological findings in jaundiced rats. Dig. Dis. Sci. 47, 929-934
65. Cinel, I., Buyukafsar, K., Cinel, L., Polat, A., Atici, S., Tamer, L., and Oral, U. (2002) The role of poly(ADP-ribose) synthetase inhibition in preventing endotoxemia-induced intestinal epithelial apoptosis. Pharmacol Res. 46, 119-127
66. Sayeed, M. M. (2003) Intestinal epithelial regenerative capacity: an "Achilles' heel" in trauma/burn/sepsis injuries? Crit. Care Med. 31, 1864-1866
67. Wilson, J. X., and Young, G. B. (2003) Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts. Can. J. Neurol. Sci. 30, 98-105
68. Gray, H. W. (2002) The natural history of venous thromboembolism: impact on ventilation/perfusion scan reporting. Semin. Nucl. Med. 32, 159-172
69. Fowler, D. E., and Wang, P. (2002) The cardiovascular response in sepsis: proposed mechanisms of the beneficial effect of adrenomedullin and its binding protein (review). Int. J. Mol. Med. 9, 443-449
70. Power, C., Fanning, N., and Redmond, H. P. (2002) Cellular apoptosis and organ injury in sepsis: a review. Shock 18, 197-211
71. Oruz, A., Justo, P., Sanz, A., Lorz, C., and Egido, J. (2003) Targeting apoptosis in acute tubular injury. Biochem. Pharmacol. 66, 1589-1594
72. Volk, H. D., Reinke, P., Krausch, D., Zuckermann, H., Asadullah, K., Muller, J. M., Docke, W. D., and Kox, W. J. (1996) Monocyte deactivation- rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 22, Suppl. 4, S474-S481
73. Goronzy, J., Weyand, C., Quan, J., Fathman, C. G., and O'Hanley, P. (1989) Enhanced cell-mediated protection against fatal Escherichia coli septicemia induced by treatment with recombinant IL-2. J. Immunol. 142, 1134-1138
74. Docke, W. D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H. D., and Kox, W. (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3, 678-681